Jennifer Doyle1, Yunfei Yang2, Jonathan H Norris2, Sher A Aslam2,3. 1. Oxford Eye Hospital, John Radcliffe Hospital, Headley Way, Oxford, OX3 9DU, UK. Jennifer.doyle307@gmail.com. 2. Oxford Eye Hospital, John Radcliffe Hospital, Headley Way, Oxford, OX3 9DU, UK. 3. Nuffield Laboratory of Ophthalmology, Department of Clinical Neurosciences, Levels 5-6 West Wing, University of Oxford, John Radcliffe Hospital, Headley Way, Oxford, OX3 9DU, UK.
Abstract
AIM: The aim of this study is to determine whether there is any difference in the quality of life of patients with a blind eye with long-term silicone oil compared to without. METHOD: Patients with either long-term silicone oil in situ (N = 17), defined as a period greater than 6 months duration with no plan for future removal, or those with a phthisical, non oil-filled eye were identified (N = 13). Two validated questionnaires (NEI VFQ-25 and the FACE-Q) that cover indicators for visual function, pain and cosmesis were sent to all patients in the two cohorts. RESULTS: There was no significant difference found in quality of life outcomes between the two groups in terms of visual function, pain or cosmesis. CONCLUSION: The results of this study support a holistic approach to the consent process before vitreoretinal surgery. Patients that may need to undergo multiple vitreoretinal procedures, where the endstage result is a long-term silicone oil fill, should be informed that their functional outcome may be similar to having no surgical intervention.
AIM: The aim of this study is to determine whether there is any difference in the quality of life of patients with a blind eye with long-term silicone oil compared to without. METHOD:Patients with either long-term silicone oil in situ (N = 17), defined as a period greater than 6 months duration with no plan for future removal, or those with a phthisical, non oil-filled eye were identified (N = 13). Two validated questionnaires (NEI VFQ-25 and the FACE-Q) that cover indicators for visual function, pain and cosmesis were sent to all patients in the two cohorts. RESULTS: There was no significant difference found in quality of life outcomes between the two groups in terms of visual function, pain or cosmesis. CONCLUSION: The results of this study support a holistic approach to the consent process before vitreoretinal surgery. Patients that may need to undergo multiple vitreoretinal procedures, where the endstage result is a long-term silicone oil fill, should be informed that their functional outcome may be similar to having no surgical intervention.
Entities:
Keywords:
Consent; Phthsis; Quality of life; Silicone oil; Vitreoretinal surgery
Authors: Y K Ghosh; S Banerjee; A Konstantinidis; I Athanasiadis; G R Kirkby; A K Tyagi Journal: Eur J Ophthalmol Date: 2008 Jan-Feb Impact factor: 2.597
Authors: Maarten J Ottenhof; Inge J Veldhuizen; Lusanne J V Hensbergen; Louise L Blankensteijn; Wichor Bramer; Berend Vd Lei; Maarten M Hoogbergen; René R W J Hulst; Chris J Sidey-Gibbons Journal: Aesthetic Plast Surg Date: 2022-06-28 Impact factor: 2.326